| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.19 | 0.3 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.054 | 0.3 |